Amrit Ray
Directeur/Membre du Conseil chez ULTRAGENYX PHARMACEUTICAL INC.
Fortune : 463 626 $ au 30/04/2024
Postes actifs de Amrit Ray
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Directeur/Membre du Conseil | 19/04/2022 | - |
| Independent Dir/Board Member | 19/04/2022 | - | |
| FORTREA HOLDINGS INC. | Directeur/Membre du Conseil | 29/06/2023 | - |
| Independent Dir/Board Member | 29/06/2023 | - | |
CorEvitas LLC
 CorEvitas LLC BiotechnologyHealth Technology CorEvitas LLC engages in the provision of medical research services. It offers real-world evidence solutions; safety; patient engagement; precision medicine biorepository. The company was founded by Joel Kremer in 2001 and is headquartered in Waltham, MA. | Directeur/Membre du Conseil | 03/08/2021 | - |
Everylife Foundation for Rare Diseases
 Everylife Foundation for Rare Diseases Miscellaneous Commercial ServicesCommercial Services EveryLife Foundation for Rare Diseases is a non-profit organization that aims to advance the development of treatment and diagnostic opportunities for rare disease patients through science-driven public policy. The non-profit company is based in Novato, CA and was founded by Emil D. Kakkis. The foundation provides training, education, resources, and opportunities to make patient voices heard, with the belief that activating the patient advocate can change public policy and save lives. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Amrit Ray
Anciens postes connus de Amrit Ray
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Biohaven Pharmaceuticals, Inc.
 Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Biohaven Pharmaceuticals, Inc. engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. The company in July 2013 and is headquartered in New Haven, CT. | Corporate Officer/Principal | 01/03/2022 | 01/12/2022 |
| PFIZER, INC. | Directeur Technique/Scientifique/R&D | 01/01/2017 | 01/01/2021 |
| JOHNSON & JOHNSON | Directeur Technique/Scientifique/R&D | - | - |
Formation de Amrit Ray
| The University of Edinburgh | Doctorate Degree |
| Tuck School of Business at Dartmouth | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 9 |
| Royaume-Uni | 2 |
Opérationnelle
| Director/Board Member | 4 |
| Independent Dir/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectorielle
| Health Technology | 5 |
| Commercial Services | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| FORTREA HOLDINGS INC. | Commercial Services |
| JOHNSON & JOHNSON | Health Technology |
| PFIZER, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
CorEvitas LLC
CorEvitas LLC BiotechnologyHealth Technology CorEvitas LLC engages in the provision of medical research services. It offers real-world evidence solutions; safety; patient engagement; precision medicine biorepository. The company was founded by Joel Kremer in 2001 and is headquartered in Waltham, MA. | Health Technology |
Biohaven Pharmaceuticals, Inc.
Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Biohaven Pharmaceuticals, Inc. engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. The company in July 2013 and is headquartered in New Haven, CT. | Commercial Services |
Everylife Foundation for Rare Diseases
Everylife Foundation for Rare Diseases Miscellaneous Commercial ServicesCommercial Services EveryLife Foundation for Rare Diseases is a non-profit organization that aims to advance the development of treatment and diagnostic opportunities for rare disease patients through science-driven public policy. The non-profit company is based in Novato, CA and was founded by Emil D. Kakkis. The foundation provides training, education, resources, and opportunities to make patient voices heard, with the belief that activating the patient advocate can change public policy and save lives. | Commercial Services |